1. Wilson JR, Forgione N, Fehlings MG. Emerging therapies for acute traumatic spinal cord injury. CMAJ 2013 185:485–492. PMID:
23228995.
2. Baptiste DC, Fehlings MG. Update on the treatment of spinal cord injury. Prog Brain Res 2007 161:217–233. PMID:
17618980.
3. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008 25:E2.
4. American Spinal Cord Injury Association. Standards for neurological classification of spinal cord injury patients. Richmond: American Spinal Cord Injury Association; 1990.
5. Waters RL, Adkins RH, Yakura JS. Definition of complete spinal cord injury. Paraplegia 1991 29:573–581. PMID:
1787981.
6. Tator CH, Hashimoto R, Raich A, et al. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine 2012 17:157–229. PMID:
22985382.
7. Andrews TC, Ballantyne CM, Hsia JA, Kramer JH. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Am J Med 2001 111:185–191. PMID:
11530028.
8. Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 2005 19:117–125. PMID:
15660968.
9. Weitz-Schmidt G. Statins as anti-inflammatory agents. Trends Pharmacol Sci 2002 23:482–486. PMID:
12368073.
10. Holmberg E, Nordstrom T, Gross M, Kluge B, Zhang SX, Doolen S. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury. J Neurotrauma 2006 23:1366–1378. PMID:
16958588.
11. Mann CM, Lee JH, Hillyer J, Stammers AM, Tetzlaff W, Kwon BK. Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury. Exp Neurol 2010 221:285–295. PMID:
19931252.
12. Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 2007 13:208–213. PMID:
17519364.
13. Stuve O, Youssef S, Steinman L, Zamvil SS. Statins as potential therapeutic agents in neuroinflammatory disorders. Curr Opin Neurol 2003 16:393–401. PMID:
12858078.
14. Pannu R, Barbosa E, Singh AK, Singh I. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res 2005 79:340–350. PMID:
15605375.
15. Pannu R, Christie DK, Barbosa E, Singh I, Singh AK. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. J Neurochem 2007 101:182–200. PMID:
17217414.
16. Pathak NN, Balaganur V, Lingaraju MC, et al. Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels. Neurochem Int 2014 68:1–9. PMID:
24513038.
17. Firth AM, Haldane SL. Development of a scale to evaluate postoperative pain in dogs. J Am Vet Med Assoc 1999 214:651–659. PMID:
10088012.
18. Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc 2000 216:1089–1091. PMID:
10754668.
19. Conzemius MG, Hill CM, Sammarco JL, Perkowski SZ. Correlation between subjective and objective measures used to determine severity of postoperative pain in dogs. J Am Vet Med Assoc 1997 210:1619–1622. PMID:
9170089.
20. Wilson JR, Cho N, Fehlings MG,Acute traumatic spinal cord injury: epidemiology, evaluation, and management. Patel V, Patel A, Harrop J, Burger E, editors. Spine surgery basics. Berlin: Springer; 2014. p.399–409.
21. Keane RW, Davis AR, Dietrich WD. Inflammatory and apoptotic signaling after spinal cord injury. J Neurotrauma 2006 23:335–344. PMID:
16629620.
22. Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 2001 21:6480–6491. PMID:
11517237.
23. Leist M, Fava E, Montecucco C, Nicotera P. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur J Neurosci 1997 9:1488–1498. PMID:
9240406.
24. Yamada M, Huang Z, Dalkara T, et al. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab 2000 20:709–717. PMID:
10779015.
25. Pahan K, Sheikh FG, Namboodiri AM, Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997 100:2671–2679. PMID:
9389730.
26. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005 45:89–118. PMID:
15822172.
27. Ziajka PE, Wehmeier T. Peripheral neuropathy and lipid-lowering therapy. South Med J 1998 91:667–668. PMID:
9671841.
28. Wang CX, Olschowka JA, Wrathall JR. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 1997 759:190–196. PMID:
9221936.
29. Yang D, Han Y, Zhang J, Chopp M, Seyfried DM. Statins enhance expression of growth factors and activate the PI3K/Akt-mediated signaling pathway after experimental intracerebral hemorrhage. World J Neurosci 2012 2:74–80. PMID:
23482588.
30. Stepien KM, Tomaszewski M, Luszczki JJ, Czuczwar SJ. The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model. Eur J Pharmacol 2012 674:20–26. PMID:
22056838.